Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2016

19.02.2016 | Original Article

A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results

verfasst von: Ben Boursi, Ronac Mamtani, Wei-Ting Hwang, Kevin Haynes, Yu-Xiao Yang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Current risk scores for colorectal cancer (CRC) are based on demographic and behavioral factors and have limited predictive values.

Aim

To develop a novel risk prediction model for sporadic CRC using clinical and laboratory data in electronic medical records.

Methods

We conducted a nested case–control study in a UK primary care database. Cases included those with a diagnostic code of CRC, aged 50–85. Each case was matched with four controls using incidence density sampling. CRC predictors were examined using univariate conditional logistic regression. Variables with p value <0.25 in the univariate analysis were further evaluated in multivariate models using backward elimination. Discrimination was assessed using receiver operating curve. Calibration was evaluated using the McFadden’s R2. Net reclassification index (NRI) associated with incorporation of laboratory results was calculated. Results were internally validated.

Results

A model similar to existing CRC prediction models which included age, sex, height, obesity, ever smoking, alcohol dependence, and previous screening colonoscopy had an AUC of 0.58 (0.57–0.59) with poor goodness of fit. A laboratory-based model including hematocrit, MCV, lymphocytes, and neutrophil–lymphocyte ratio (NLR) had an AUC of 0.76 (0.76–0.77) and a McFadden’s R2 of 0.21 with a NRI of 47.6 %. A combined model including sex, hemoglobin, MCV, white blood cells, platelets, NLR, and oral hypoglycemic use had an AUC of 0.80 (0.79–0.81) with a McFadden’s R2 of 0.27 and a NRI of 60.7 %. Similar results were shown in an internal validation set.

Conclusion

A laboratory-based risk model had good predictive power for sporadic CRC risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed
2.
Zurück zum Zitat American Cancer Society. Colorectal Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015. American Cancer Society. Colorectal Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015.
3.
5.
Zurück zum Zitat Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancer. N Engl J Med. 1988;319:533–537.CrossRefPubMed Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancer. N Engl J Med. 1988;319:533–537.CrossRefPubMed
6.
Zurück zum Zitat Levin B, Lieberman D, McFarland B, et al. Screening and surveillance for the early detection of CRC and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-society Task Force on CRC, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed Levin B, Lieberman D, McFarland B, et al. Screening and surveillance for the early detection of CRC and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-society Task Force on CRC, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed
7.
Zurück zum Zitat Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–521.CrossRefPubMed Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–521.CrossRefPubMed
8.
Zurück zum Zitat Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921.CrossRefPubMedPubMedCentral Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.CrossRefPubMedPubMedCentral Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN, et al. The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1983.CrossRefPubMed Winawer SJ, Zauber AG, Ho MN, et al. The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1983.CrossRefPubMed
11.
Zurück zum Zitat Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7:562–567.CrossRefPubMed Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7:562–567.CrossRefPubMed
13.
Zurück zum Zitat Sint NJ, de Jonge V, van Baalen O, et al. Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy. 2013;45:545–552.CrossRef Sint NJ, de Jonge V, van Baalen O, et al. Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy. 2013;45:545–552.CrossRef
14.
Zurück zum Zitat Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886.CrossRefPubMed Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886.CrossRefPubMed
15.
Zurück zum Zitat Optenberg SA, Clark JY, Brawer MK, Thompson IM, Stein CR, Friedrichs P. Development of a decision-making tool to predict risk of prostate cancer: the cancer of the prostate risk index (CAPRI) test. Urology. 1997;50:665–672.CrossRefPubMed Optenberg SA, Clark JY, Brawer MK, Thompson IM, Stein CR, Friedrichs P. Development of a decision-making tool to predict risk of prostate cancer: the cancer of the prostate risk index (CAPRI) test. Urology. 1997;50:665–672.CrossRefPubMed
16.
Zurück zum Zitat Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11:477–488.CrossRefPubMed Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11:477–488.CrossRefPubMed
17.
Zurück zum Zitat Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–263.CrossRefPubMed Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–263.CrossRefPubMed
18.
Zurück zum Zitat Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.CrossRefPubMedPubMedCentral Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–1241.CrossRefPubMed Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–1241.CrossRefPubMed
20.
Zurück zum Zitat Wong MC, Lam TY, Tsoi KK, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63:1130–1136.CrossRefPubMed Wong MC, Lam TY, Tsoi KK, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63:1130–1136.CrossRefPubMed
21.
Zurück zum Zitat Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–693.CrossRefPubMed Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–693.CrossRefPubMed
22.
Zurück zum Zitat Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–698.CrossRefPubMed Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–698.CrossRefPubMed
23.
Zurück zum Zitat Lubin JH, Gail MH. Biased selection of controls for case–control analysis of cohort studies. Biometrics. 1984;40:63–75.CrossRefPubMed Lubin JH, Gail MH. Biased selection of controls for case–control analysis of cohort studies. Biometrics. 1984;40:63–75.CrossRefPubMed
24.
Zurück zum Zitat Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18:76–83.CrossRefPubMed Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18:76–83.CrossRefPubMed
25.
Zurück zum Zitat Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171–177.PubMed Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171–177.PubMed
26.
Zurück zum Zitat Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393–401.CrossRefPubMed Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393–401.CrossRefPubMed
27.
Zurück zum Zitat Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19:251–255.PubMed Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19:251–255.PubMed
28.
Zurück zum Zitat Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in the health improvement network. Pharmacoepidemiol Drug Saf. 2009;18:730–736.CrossRefPubMed Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in the health improvement network. Pharmacoepidemiol Drug Saf. 2009;18:730–736.CrossRefPubMed
29.
Zurück zum Zitat Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14:443–451.CrossRefPubMed Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14:443–451.CrossRefPubMed
30.
Zurück zum Zitat Maringe C, Walters S, Rachet B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52:919–932.CrossRefPubMed Maringe C, Walters S, Rachet B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52:919–932.CrossRefPubMed
31.
Zurück zum Zitat Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137.PubMed Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137.PubMed
32.
Zurück zum Zitat Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512–5528.CrossRefPubMed Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512–5528.CrossRefPubMed
33.
Zurück zum Zitat Binder H, Sauerbrei W, Royston P. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response. Stat Med. 2013;32:2262–2277.CrossRefPubMed Binder H, Sauerbrei W, Royston P. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response. Stat Med. 2013;32:2262–2277.CrossRefPubMed
34.
Zurück zum Zitat McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, ed. Frontiers in Econometrics. New York: Academic Press; 1974:105–142. McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, ed. Frontiers in Econometrics. New York: Academic Press; 1974:105–142.
35.
Zurück zum Zitat Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed
36.
Zurück zum Zitat Spell DW, Jones DV Jr, Harper WF, Bessman D. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed Spell DW, Jones DV Jr, Harper WF, Bessman D. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed
37.
Zurück zum Zitat Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anemia in diagnosing colorectal cancer: a case–control study using electronic primary care records. Br J Cancer. 2008;98:323–327.CrossRefPubMedPubMedCentral Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anemia in diagnosing colorectal cancer: a case–control study using electronic primary care records. Br J Cancer. 2008;98:323–327.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Tchebiner JZ, Nutman A, Boursi B, et al. Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci. 2011;342:395–401.CrossRefPubMed Tchebiner JZ, Nutman A, Boursi B, et al. Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci. 2011;342:395–401.CrossRefPubMed
39.
Zurück zum Zitat Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed
40.
Zurück zum Zitat Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–1634.CrossRefPubMed Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–1634.CrossRefPubMed
41.
Zurück zum Zitat Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–1106.CrossRefPubMed Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–1106.CrossRefPubMed
43.
Zurück zum Zitat Pencina MJ, Steyerberg EW, D’Agostino RB. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.CrossRefPubMed Pencina MJ, Steyerberg EW, D’Agostino RB. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.CrossRefPubMed
44.
Zurück zum Zitat Pankratz VS, Degnim AC, Frank RD, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33:923–929.CrossRefPubMedPubMedCentral Pankratz VS, Degnim AC, Frank RD, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33:923–929.CrossRefPubMedPubMedCentral
Metadaten
Titel
A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results
verfasst von
Ben Boursi
Ronac Mamtani
Wei-Ting Hwang
Kevin Haynes
Yu-Xiao Yang
Publikationsdatum
19.02.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4081-x

Weitere Artikel der Ausgabe 7/2016

Digestive Diseases and Sciences 7/2016 Zur Ausgabe

DDS-GRG Profiles and Perspectives

GRG Profiles: Jackie D. Wood

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.